Gene
SLC39A4
solute carrier family 39 member 4
Explore in graph →CI-GENE-00031235HGNC:17129 ENSG00000147804 NCBI 55630 Cancer geneApproved
Curated evidence
Clinical evidence (0)
CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.
Data not yet available
No curated evidence item involves this gene yet.
Cohorts
Alteration frequency by cohort (4)
Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.
gdcProvenance
- Source
- NCI Genomic Data Commons (open aggregated data)
- Dataset
- GDC top mutated genes by project
- Version
- Data Release 46.0
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- cohort
- License
- Open-access GDC data (NCI); citation of GDC and originating program requested
- Run
- ING-GDC-20260908-000001
| Cohort | Mapped cancer | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Rank in cohort | Source |
|---|---|---|---|---|---|---|---|
| Ovarian Serous Cystadenocarcinoma TCGA-OV | Ovarian Serous Cystadenocarcinoma | Ssm | 439 | 603 | 72.8% | 97 | gdc |
| Triple Negative Breast Cancer (DLDCCC, Cancer Discov 2022) |
Literature
Linked publications (0)
Data not yet available
No publication linked to this gene yet.